Brain State Technologies (Scottsdale, Arizona) announces that use of their allostatic neurotechnology was associated with positive effects for the cardiovascular system and reduction of inflammation, in individuals with diverse health conditions. The findings are being presented at the Council on Hypertension of the American Heart Association, meeting in Orlando, Florida from September 14-17.
(PRWeb September 19, 2016)
Read the full story at http://www.prweb.com/releases/2016/09/prweb13693303.htm
For more information, please visit
http://www.prweb.com/releases/2016/09/prweb13693303.htm